Results 111 to 120 of about 100,395 (290)

Isotretinoin and Hidradenitis Suppurativa a Conflictual Binomial: Investigation on Differential Response Rate Between Inflammatory and Follicular Phenotype

open access: yesJEADV Clinical Practice, EarlyView.
A cohort of 21 HS patients treated with isotretinoin was enrolled in this study. The main outcome was HISCR50 achievement at week 16. Overall, 2/12 patients affected by follicular phenotype of HS and 2/9 patients affected by inflammatory phenotype of HS achieved HISCR50 at week 16. No significant difference was found in response to isotretinoin between
Maria Vittoria Cannizzaro   +6 more
wiley   +1 more source

Health-related Quality of Life in Women with Polycystic Ovary Syndrome

open access: yesMedisur, 2014
Polycystic ovary syndrome is the most frequent endocrine and metabolic disorder in women of reproductive age. Its characteristic signs and symptoms are menstrual irregularities, amenorrhea, acne, hirsutism, obesity and infertility.
Belén Carazo Hernández   +5 more
doaj   +2 more sources

Polycystic ovary syndrome and chronic pain among females and individuals of childbearing age: A scoping review

open access: yesSAGE Open Medicine
Objectives: The purpose of this scoping review is to explore research studies on the association between chronic pain and polycystic ovary syndrome to create local (U.S.-based) and global recommendations to improve access to and quality of affordable ...
Lea Sacca   +7 more
doaj   +1 more source

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance

open access: yesБюллетень сибирской медицины, 2018
Aim. Polycystic ovary syndrome is a common cause of infertility. In addition, polycystic ovary syndrome is often associated with metabolic complications. In most women hyperandrogenic manifestations occur during puberty.
E. M. Bogatyreva, G. A. Novik
doaj   +1 more source

Polycystic ovary syndrome [PDF]

open access: yesHuman Reproduction, 1996
R, Homburg, L C, Giudice, R J, Chang
openaire   +2 more sources

Psychodermatology of the Female: Hormones, Skin and Mental Health Across the Lifespan

open access: yesJEADV Clinical Practice, EarlyView.
Hormonal transitions across the female lifespan shape skin disease and psychiatric comorbidity through the brain–skin axis and Neuro‐Immuno‐Cutaneous‐Endocrine (NICE) network. This narrative review links puberty, menstruation, pregnancy, postpartum and menopause to dermatologic and psychosocial outcomes.
Sheila Sharifi   +4 more
wiley   +1 more source

A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS

open access: yesWomen's Health
Polycystic ovary syndrome is a common reproductive endocrine condition that affects women of fertile age and is characterized by three main features, including hyperandrogenism, chronic anovulation, and polycystic ovaries. In addition, half of women with
Salwa Bader   +3 more
doaj   +1 more source

Lipid Profile in Primary Aldosteronism: Cross‐Sectional and Post‐Treatment Analyses

open access: yesLipids, EarlyView.
ABSTRACT The relationship between primary aldosteronism (PA) and lipid metabolism remains controversial, with inconsistent findings reported in the literature. This study aimed to clarify PA's impact on the lipid profile using both a cross‐sectional comparison with essential hypertension (EH) controls and a longitudinal within‐patient pre‐post ...
Meriem Yazidi   +7 more
wiley   +1 more source

Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study

open access: yesF&S Reports
Objective: To assess the counseling experiences of patients with polycystic ovary syndrome (PCOS) related to obstetric complications and preconception management of comorbidities. Design: Cross-sectional survey study. Setting: Not applicable. Patient(s):
Anne E. Kim, M.D.   +3 more
doaj   +1 more source

Twenty‐Four Month Outcomes From a Real‐World Telehealth Obesity Treatment Clinic Using Obesity Medications

open access: yesObesity, EarlyView.
ABSTRACT Objective Antiobesity medications (AOMs) are indicated for long‐term use; however, evidence of their real‐world long‐term efficacy is limited. This study describes clinical outcomes from 18‐ and 24‐month use of AOMs in a telemedicine weight management clinic.
Kathleen R. Ruddiman   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy